Interruption of HBV intrauterine transmission: A clinical study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

446

HTML

4179

Tables (1-2)

257

Sum=4882

Jul 15, 2003 (publication date) through Mar 2, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Jul 15, 2003; 9(7): 1501-1503
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1501

Table 2 Incidence of neonatal intrauterine infection in 3 groups

^aP > 0.05 between HBIG group and lamivudine group;

^bP < 0.05 vs HBIG group or lamivudine group.

Citation: Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: A clinical study. World J Gastroenterol 2003; 9(7): 1501-1503
URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1501.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i7.1501